X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-29.26%
202473.27%
202331.40%
20229.38%
202117.95%
202031.15%
201984.90%
201810.58%
201725.66%
2016261.55%